Market size in 2024 | US$ 785.4 million |
Forecast Market size by 2030 | US$ 985.6 million |
---|---|---|---|
Growth Rate | CAGR of 3.8% | Number of Pages | 205 Pages |
Europe Acetaminophen market size was valued at US$ 785.4 million in 2024 and is projected to reach US$ 985.6 million by 2030, at a CAGR of 3.8% during the forecast period 2024-2030.
Common analgesic and antipyretic drug.
Pharmaceutical manufacturing (60%,
Report Attributes | Report Details |
---|---|
Report Title | Europe Acetaminophen Market Outlook and Forecast 2024-2030 |
Market size in 2024 | US$ 785.4 million |
Forecast Market size by 2030 | US$ 985.6 million |
Growth Rate | CAGR of 3.8% |
Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
Base Year | 2023 |
Forecast Year | 2031 |
Number of Pages | 205 Pages |
Customization Available | Yes, the report can be customized as per your need. |
1.1 Product Overview and Scope of Acetaminophen
1.2.1 Europe Market Size YoY Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Powder Grade
1.2.3 Direct Compression Grade
1.3.1 Europe Market Size YoY Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Tablet Drug
1.3.3 Granule Drug
1.3.4 Oral Drug
1.3.5 Other
1.4 Europe Market Growth Prospects
1.4.1 Europe Revenue Estimates and Forecasts (2019-2030)
1.4.2 Europe Production Estimates and Forecasts (2019-2030)
2.1 Industry Trends
2.1.1 SWOT Analysis
2.1.2 PESTEL Analysis
2.1.3 Porter’s Five Forces Analysis
2.2 Potential Market and Growth Potential Analysis
3.1 Europe Production by Manufacturers (2019-2023)
3.2 Europe Revenue Market Share by Manufacturers (2019-2023)
3.3 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Europe Average Price by Manufacturers (2019-2023)
3.5 Manufacturers Production Sites, Area Served, Product Type
3.6 Market Competitive Situation and Trends
3.6.1 Market Concentration Rate
3.6.2 Europe 5 and 10 Largest Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4.1 Europe Production
4.1.1 Europe Production YoY Growth Rate (2019-2023)
4.1.2 Europe Production, Revenue, Price and Gross Margin (2019-2024)
5.1 Europe
5.1.1 Europe Consumption by Country
5.1.2 Europe Sales, Consumption, Export, Import (2019-2023)
5.1.1 Germany
5.2.2 United Kingdom
5.3.3 France
5.4.4 Italy
5.5.5 Spain
5.6.6 Netherlands
5.7.7 Belgium
6.1 Europe Production Market Share by Type (2019-2024)
6.2 Europe Revenue Market Share by Type (2019-2024)
6.3 Europe Price by Type (2019-2024)
7.1 Europe Production Market Share by Application (2019-2024)
7.2 Europe Revenue Market Share by Application (2019-2024)
7.3 Europe Price by Application (2019-2024)
8.1 GlaxoSmithKline
8.1.1 GlaxoSmithKline Corporation Information
8.1.2 GlaxoSmithKline Product Portfolio
8.1.3 GlaxoSmithKline Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.1.4 GlaxoSmithKline Main Business and Markets Served
8.1.5 GlaxoSmithKline Recent Developments/Updates
8.2 Novartis AG
8.2.1 Novartis AG Corporation Information
8.2.2 Novartis AG Product Portfolio
8.2.3 Novartis AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.2.4 Novartis AG Main Business and Markets Served
8.2.5 Novartis AG Recent Developments/Updates
8.3 Bayer AG
8.3.1 Bayer AG Corporation Information
8.3.2 Bayer AG Product Portfolio
8.3.3 Bayer AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.3.4 Bayer AG Main Business and Markets Served
8.3.5 Bayer AG Recent Developments/Updates
8.4 Sanofi
8.4.1 Sanofi Corporation Information
8.4.2 Sanofi Product Portfolio
8.4.3 Sanofi Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.4.4 Sanofi Main Business and Markets Served
8.4.5 Sanofi Recent Developments/Updates
8.5 Reckitt Benckiser Group
8.5.1 Reckitt Benckiser Group Corporation Information
8.5.2 Reckitt Benckiser Group Product Portfolio
8.5.3 Reckitt Benckiser Group Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.5.4 Reckitt Benckiser Group Main Business and Markets Served
8.5.5 Reckitt Benckiser Group Recent Developments/Updates
8.6 Johnson & Johnson
8.6.1 Johnson & Johnson Corporation Information
8.6.2 Johnson & Johnson Product Portfolio
8.6.3 Johnson & Johnson Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.6.4 Johnson & Johnson Main Business and Markets Served
8.6.5 Johnson & Johnson Recent Developments/Updates
8.7 Stada Arzneimittel AG
8.7.1 Stada Arzneimittel AG Corporation Information
8.7.2 Stada Arzneimittel AG Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.7.3 Stada Arzneimittel AG Main Business and Markets Served
8.7.4 Stada Arzneimittel AG Recent Developments/Updates
8.8 Teva Pharmaceutical Industries Ltd.
8.8.1 Teva Pharmaceutical Industries Ltd. Corporation Information
8.8.2 Teva Pharmaceutical Industries Ltd. Product Portfolio
8.8.3 Teva Pharmaceutical Industries Ltd. Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.8.4 Teva Pharmaceutical Industries Ltd. Main Business and Markets Served
8.8.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
8.9 Boehringer Ingelheim
8.9.1 Boehringer Ingelheim Corporation Information
8.9.2 Boehringer Ingelheim Product Portfolio
8.9.3 Boehringer Ingelheim Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.9.4 Boehringer Ingelheim Main Business and Markets Served
8.9.5 Boehringer Ingelheim Recent Developments/Updates
8.10 AstraZeneca
8.10.1 AstraZeneca Corporation Information
8.10.2 AstraZeneca Product Portfolio
8.10.3 AstraZeneca Production Capacity, Revenue, Price and Gross Margin (2019-2024)
8.10.4 AstraZeneca Main Business and Markets Served
8.10.5 AstraZeneca Recent Developments/Updates
9.1 Key Raw Materials Analysis
9.1.1 Key Raw Materials
9.1.2 Key Suppliers of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
9.3 Manufacturing Process Analysis of Acetaminophen
9.4 Industrial Chain Analysis
10.1 Marketing Channel
10.2 Distributors List
10.3 Customers
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12.1 Europe Production, Revenue Forecast (2024-2030)
13.1 Europe Forecasted Consumption of by Country
14.1 Europe Production, Revenue and Price Forecast by Type (2024-2030)
14.1.1 Europe Forecasted Production of by Type (2024-2030)
14.1.2 Europe Forecasted Revenue of by Type (2024-2030)
14.1.3 Europe Forecasted Price of by Type (2024-2030)
14.2 Europe Production, Revenue and Price Forecast by Application (2024-2030)
14.2.1 Europe Forecasted Production of by Application (2024-2030)
14.2.2 Europe Forecasted Revenue of by Application (2024-2030)
14.2.3 Europe Forecasted Price of by Application (2024-2030)
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Author List
16.4 Disclaimer
17.1 Note
17.2 Examples of Clients
Frequently Asked Questions ?